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Kupffer cells are the resident macrophage population 
of the liver and have previously been implicated in the 
pathogenesis of hepatic ischemia–reperfusion injury (IRI). 
Kupffer cells are the major site of expression of hepatic 
heme oxygenase-1 (HO-1), which has been shown to 
have anti-inflammatory actions and to protect animals 
and cells from oxidative injury. Kupffer cells and circulat-
ing monocytes were selectively ablated using liposomal 
clodronate (LC) in the CD11b DTR mouse before induc-
tion of hepatic ischemia. Kupffer cell depletion resulted 
in loss of HO-1 expression and increased susceptibility to 
hepatic IRI, whereas ablation of circulating monocytes 
did not affect IRI phenotype. Targeted deletion of HO-1 
rendered mice highly susceptible to hepatic IRI. In vivo, 
HO-1 deletion resulted in pro-inflammatory Kupffer 
cell differentiation characterized by enhanced Ly6c 
and MARCO (macrophage receptor with collagenous 
structure) expression as well as decreased F4/80 expres-
sion, mirrored by an expansion in immature circulating 
monocytes. In vitro, HO-1 inhibition throughout mac-
rophage differentiation led to increased cell numbers, 
and pro-inflammatory Ly6c+ CD11c− F4/80− pheno-
type. These data support a critical role for tissue-resident 
macrophages in homeostasis following ischemic injury, 
and a co-dependence of HO-1 expression and tissue-
resident macrophage differentiation.
Received 14 July 2008; accepted 17 September 2008; published online 
11 November 2008. doi:10.1038/mt.2008.237
IntroductIon
As key mediators of immune responses following hepatic injury, 
Kupffer cells have been implicated in the pathogenesis of ischemia–
reperfusion injury (IRI). Antigen presenting cells (APCs) are at 
the heart of the pathway of immune activation described by the 
“danger model.”1 When activated by danger associated molecular 
patterns (DAMPs) released by injured parenchymal cells, APCs 
secrete pro-inflammatory cytokines, activate T cells, and initiate 
neutrophil chemotaxis.2 “Classical” activation is  characterized 
by secretion of pro-inflammatory cytokines including IL-1β and 
TNF-α, while “alternate” activation is characterized by secretion 
of anti-inflammatory IL-10. Analogous to “classical” and “alter-
nate” modes of macrophage activation, macrophage differen-
tiation has been shown to proceed broadly down two divergent 
pathways. One population, termed “inflammatory monocytes” 
express CCR2 and are attracted to acutely inflamed sites by MIP-1 
signaling: these cells also express the antigen Ly6c. The second 
group, termed “resident” monocytes, express CX3CR1, patrolling, 
and re-populating resting tissues.3 These cells also express the cell 
surface marker CD11c.4
Modulation of immune activation at any stage has been shown 
to protect animals from IRI. Interruption of DAMPs,5 Toll-like 
receptors (TLRs),6 pro-inflammatory cytokines,7 T-cell receptors,8 
co- stimulatory pathways,9 or T cells10 have all been shown to ame-
liorate IRI. Experimental modulation of Kupffer cell function has 
been attempted using gadolinium chloride and glycine. Although 
the mechanisms through which these reagents have their protec-
tive effects are incompletely characterized, both have been shown 
to suppress TNF-α secretion11 and to ameliorate IRI. This has been 
taken to imply that Kupffer cells have a broadly harmful effect fol-
lowing ischemic injury.
Heme oxygenase-1 (HO-1) catalyzes the degradation of heme 
into biliverdin, free iron, and carbon monoxide. In the liver, it is 
expressed principally by Kupffer cells.12 HO-1 induction protects 
cells and animals from IRI by modulation of every stage of the 
immune activation pathway. It confers direct cytoprotection13 
which may limit production of DAMPs, mediates the protected 
phenotype arising from interruption of TLR signaling,14 switches 
macrophages in vitro from “classical” to “alternate” activation,15 
modulates T-cell activation, and enhances immunological 
tolerance.16
In light of the anti-inflammatory role of HO-1, we hypoth-
esized that inhibition or deletion of this enzyme might drive 
macrophage differentiation down an inflammatory pathway. We 
demonstrate in vivo and in vitro that HO-1 is required for differ-
entiation of “resident” macrophages, which promote homeostasis, 
while suppressing expansion of inflammatory monocyte popu-
lations. By selectively depleting macrophage populations using 
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liposomal clodronate (LC)17 and diphtheria toxin in the CD11bDTR 
mouse,18 we show that Kupffer cells and not circulating monocytes 
are required for hepatocellular survival of IRI. We suggest that 
the effect of HO-1 upon macrophage differentiation is a poten-
tial avenue of investigation for the amelioration of injury in the 
wide range of human diseases caused by ischemia. Since HO-1 has 
been shown to modulate the immunopathological contribution to 
a wide range of disorders, our findings concerning its effect upon 
macrophage differentiation may have broad application.
results
Kupffer cells but not circulating monocytes are 
essential for hepatic protection from ischemic insults
First, to verify our model against others in the published literature, 
we treated animals with GdCl3 before 50′ hepatic ischemic insults 
and found them to be protected from injury (GdCl3-treated ala-
nine aminotransferase (ALT) 1929 ± 414 IU, untreated ALT4467 ± 
532 P = 0.006) (Figure 1a). Immunohistochemistry for F4/80 
demonstrated no significant anatomical ablation of Kupffer cells 
(Figure 1b). Western blotting of liver lysates from GdCl3-treated ani-
mals demonstrated HO-1 induction (Figure 1c), and pretreatment 
of bone marrow–derived monocytes (BMDMs) with GdCl3 before 
LPS stimulus resulted in decreased TNF-α secretion (Figure 1d). 
Thus, our findings were broadly in line with published data using 
this reagent, with the added observation that HO-1 was induced by 
GdCl3 without altering Kupffer cell number or spatial distribution. 
In light of these findings and previously published literature19,20 it 
is likely that GdCl3 induces a functional change in macrophages, 
which accounts for its protective effect against ischemia.
As an alternative manipulation of macrophage populations, we 
used the CD11bDTR mouse to selectively ablate tissue-resident and 
circulating macrophage populations before ischemia–reperfusion 
insults. As previously described,18 treatment of CD11bDTR mice 
with diphtheria toxin (DT) 25 ng/g i.p. resulted in loss of circulating 
monocytes (DT 2.1 × 105 monocytes/ml, PBS 7.2 × 105 monocytes/
ml P = 0.004) (Figure 2a) but sparing of Kupffer cells and splenic 
macrophages (Figure 2b). Administration of LC 100 µl i.v.17 resulted 
in complete loss of Kupffer cells from the liver, and substantial deple-
tion of splenic macrophages (Figure 2b). Whereas the systemic stress 
caused by serial blood sampling led to a progressive monocytosis in 
PBS-treated mice, this was suppressed at 24 hours in LC-treated mice 
with recovery at 48 hours after injection (Figure 2a). In keeping with 
 immunohistochemical findings that HO-1 expression is principally 
within Kupffer cells (Figure 2c), Western blotting demonstrated that 
Kupffer cell ablation arising from LC treatment led to complete loss 
of hepatic HO-1 expression, even in the ischemic liver lobe in which 
HO-1 is normally potently induced (Figure 2d).
Twenty-four hours following DT, LC, or PBS treatments, mice 
were subjected to 40-minute left hepatic ischemia–reperfusion 
insults. Following injury, circulating monocyte depleted and PBS-
treated animals were not significantly injured in terms of ALT 
release or histological injury (PBS ALT 339 ± 78 IU, Hist inj 3 ± 0.6 
arbitrary units, DT ALT 384 ± 67 IU, Hist inj 1.7 ± 1 arbitrary units) 
whereas Kupffer cell–depleted animals were highly susceptible to 
ischemia (ALT 4640 ± 790, P = 0.002, Hist inj 6.5 ± 0.5 arbitrary 
units P = 0.019) (Figure 2e,f). These data imply a homeostatic role 
for Kupffer cells but not circulating monocytes following hepatic 
ischemic injury. The focus of HO-1 expression within Kupffer cells 
and its loss following Kupffer cell ablation suggests a key role for 
this enzyme in the protection afforded by Kupffer cells.
Ho-1 expression is essential for protection from 
hepatic ischemic insults
To examine the influence of heme oxygenase in protection from 
liver IRI we studied response in wild-type, heterozygous and 
homozygous Hmox-1 deleted mice. In accordance with previously 
published pharmacological inhibitor studies, Hmox-1−/− mice 
were more susceptible to hepatic ischemic insults than Hmox-1+/− 
and +/+ animals in terms of ALT release and histological injury 
score (Figure 3a,b). Following ischemia, relative HO-1 expression 
in the nonischemic and ischemic lobes of Hmox-1+/− animals 
was approximately half that of wild-type animals (Figure 3c,d) 
(nonischemic Hmox-1+/+ 1 ± 0.11x, Hmox-1+/− 0.47 ± 0.16x, 
P = 0.04; ischemic Hmox-1+/+ 2.1 ± 0.32x, Hmox-1+/− 1.0 ± 0.25x 
P = 0.04). No HO-1 expression was seen in Hmox-1−/− animals in 
control or ischemic lobes (data not shown).
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Figure 1 the effect of gadolinium chloride. (a) Wild-type animals 
treated with GdCl 20 mg/kg IP were protected from 50 minute hepatic 
ischemic insults compared with vehicle treated controls (n = 4 per 
group). (b) Immunohistochemistry demonstrated no significant loss of 
F4/80+ Kupffer cells following GdCl administration. (c) When taken from 
animals 24 hours after GdCl treatment, liver lysates demonstrated HO-1 
induction on western blotting. (d) Pretreatment of BMDMs with GdCl 
prior to LPS stimulus decreased TNF-α secretion.
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tissue-resident macrophage differentiation is 
Ho-1 dependent. Hmox-1−/− Kupffer cells have 
inflammatory immunophenotype
Kupffer cells in resting Hmox-1+/+, +/−, and −/− mice were phe-
notyped for F4/80, CD11b, CD68 (macrosialin), CD206 (mannose 
receptor), MARCO (macrophage receptor with collagenous struc-
ture), and Ly6c. Immunohistochemical findings are summarized 
in Table 1. CD68 staining was highly abnormal in Hmox-1−/− liv-
ers, revealing dysmorphic, multinucleate cells (Figure 4).
These data suggest that HO-1 may be required for normal “res-
ident” macrophage/monocyte differentiation. Hmox-1−/− Kupffer 
cells had a distinctly inflammatory phenotype characterized by 
expression of Ly6c and MARCO (Figure 4). Ly6c, a component 
of the Gr1 epitope is associated with inflammatory monocytes.4 
MARCO is associated with “classical” macrophage activation, 
being upregulated following LPS stimulus.21,22 CD68 has also been 
associated with macrophage activation.23,24 F4/80, which is associ-
ated with modulation of adaptive immune responses,25 was absent 
from Hmox-1−/− Kupffer cells (Figure 4).
Hmox-1−/− animals have larger numbers of Immature 
circulating monocytes
Blood samples from Hmox-1−/− and Hmox-1+/+ mice were com-
pared on flow cytometry with respect to monocyte (Figure 5a–c) 
and neutrophil counts (Figure 5d). Hmox-1−/− mice had 2.1 
times more monocytes than wild-type controls (P = 0.02). This 
was made up of a large immature Gr1hi group of which there was 
a 2.5-fold increase compared with Hmox-1+/+ animals (P = 0.06). 
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Figure 2 selective depletion of monocyte/macrophage populations. CD11bDTR mice received DT to deplete circulating monocytes or LC to 
deplete Kupffer cells prior to left lobar hepatic ischemic insults (n = 4 per group). (a) Circulating monocytes were counted using flow cytometry. 
Whereas on serial sampling from BS treated mice showed a progressive monocytosis, this was transiently suppressed by LC, although monocyte counts 
recovered in these animals at 48 hours. DT treatment led to complete depletion of circulating monocytes at 24 hours. (b) Immunohistochemistry 
for F4/80 demonstrated complete ablation of Kupffer cells (KC) and significant depletion of splenic macrophages (SM) following LC but not DT 
administration. (c) In keeping with the finding that HO-1 expression is concentrated within Kupffer cells, (d) western blotting showed that Kupffer 
cell ablation led to complete loss of hepatic HO-1 expression from both right nonischemic (control, C) and left ischemic (I) lobes in which HO-1 
is normally potently induced. Twenty-four hours following PBS, LC, or DT administration, CD11bDTR animals were subjected to hepatic ischemia 
reperfusion insults. Kupffer cell but not circulating monocyte ablation led to susceptibility to ischemia reperfusion injury in terms of (e) ALT release 
and (f) histological injury score.
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An increase was also seen in Gr1lo monocytes although this did 
not achieve significance (P = 0.067). There was a trend toward 
more circulating neutrophils (1.6-fold increase compared with 
Hmox-1+/+ animals) but this did not achieve statistical signifi-
cance (P = 0.11).
These findings are consistent with the inflammatory state pre-
viously observed in Hmox-1−/− mice26 and the pro-inflammatory 
phenotype we have observed in Hmox-1−/− Kupffer cells.
Ho-1-inhibited BMdMs have inflammatory 
phenotype in vitro
In view of the progressive tissue iron overload, iron deficiency 
anemia, and chronic immune activation previously reported 
in Hmox-1−/− animals,26,27 it was important to confirm the 
role of HO-1 in macrophage maturation in vitro in the absence 
of  pro-inflammatory stimuli. Wild-type, Hmox-1+/−, and 
Hmox-1−/− bone marrow–derived hemopoeitic progenitors were 
matured for 6 days into monocytes (BMDMs) in L929 condi-
tioned medium. Wild-type cells were cultured throughout their 
maturation in the presence or absence of the highly specific HO-1 
inhibitor Chromium Mesoporphyrin IX (CrMP).28
HO-1 inhibition and deletion led to expansion of cell numbers 
(Figure 6a) as well as pleomorphism in terms of differences in 
size and granularity (not shown) compared with the homogenous 
population of cells derived from HO-1 intact mice.
In common with our in vivo observations, HO-1 inhibition in 
vitro resulted in loss of F4/80 expression. In HO-1 intact cultures, 
71 ± 1% of cells were F4/80+ whereas HO-1 inhibition reduced 
this proportion to 23.5 ± 4.6% (P = 0.002). Calculation of cell 
number indicated a trend toward a smaller absolute number of 
F4/80+ cells (untreated 17.1 ± 3.5 million cells, HO-1 inhibited 
12.2 ± 4.2 million cells, P = 0.08), and expansion of a very large 
F4/80− population in HO-1 inhibited cultures (accounting for 
their increased cell numbers) (HO-1 intact 7.2 ± 1.6 million cells, 
HO-1 inhibited 38.6 ± 7.4 million cells, P = 0.01) (Figure 6b,c).
Flow cytometry dot plots indicated that “inflammatory” 
Ly6c+ and “resident” CD11c+ subsets were mutually exclusive 
indicating divergent differentiation (Figure 6d). As we saw in our 
in vivo investigations, the inflammatory monocyte marker Ly6c 
was upregulated in HO-1-inhibited BMDMs. In HO-1 intact cul-
tures, 31.3 ± 2.2% of cells were Ly6c+ whereas in HO-1-inhibited 
cultures, 74.6 ± 1.8% cells were Ly6c+ (P = 0.0003). Calculation of 
absolute cell number indicated that the number of Ly6c+/Ly6c− 
cells in HO-1 intact cultures was 13.1 ± 1/ 16.5 ± 3 million cells, 
compared with 43.5 ± 7.1/12.7 ± 2.6 million cells in the HO-1-
inhibited group, P = 0.02/P = 0.03 (Figure 6e). The opposite was 
true of the resident macrophage marker CD11c which was much 
more frequent in HO-1 intact cultures (41.1 ± 9%) compared with 
HO-1-inhibited cultures (12.3 ± 4%), giving absolute cell counts 
of CD11c+/CD11c− in HO-1 intact cultures of 11.3 ± 4.3/13.1 ± 
1 million cells compared with 7.4 ± 4.3/43.5 ± 7.1 million cells in 
HO-1-inhibited cultures P = 0.08/P = 0.02 (Figure 6f).
HO-1 inhibition by CrMP (5 µmol/l for 1 hour) increased 
TNF-α production (1.57 ± 0.17 times untreated, P < 0.00001) 
(Figure 6g) whereas HO-1 induction by hemin (50 µmol/l over-
night) reduced TNF-α production following LPS stimulus (0.4 ± 
0.05 times untreated, P = 0.01) (Figure 6h).
These in vitro data confirm our in vivo observation that HO-1 
activity is required for “resident” patterns of macrophage dif-
ferentiation, and suppression of “inflammatory” macrophage 
populations. We also confirm in primary culture the previously 
published finding15 that HO-1 induction reduces inflamma-
tory cytokine production by macrophages. Together, these data 
indicate that HO-1 has an anti-inflammatory role which extends 
from macrophage differentiation right through to modulation of 
pro-inflammatory cytokine release. In the context of ischemia–
reperfusion insults, resident macrophages appear critical for the 
survival of surrounding parenchymal cells.
dIscussIon
In this article, we have shown that Kupffer cells are essential for 
hepatic survival of ischemia–reperfusion insults, that hepatic 
table 1 cell surface marker expression by genotype
Marker Hmox-1+/+ Hmox-1+/− Hmox-1−/−
F4/80 ++ ++ —
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CD68 ++ ++ +++
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Figure 3 the effect of Hmox-1 gene deletion. Hmox-1−/−, +/− and +/+ 
animals were subjected to 40 minute left lobar hepatic ischemic insults 
(n = 6 per group). Hmox-1−/− but not Hmox-1+/− animals were sus-
ceptible to hepatic IRI in terms of (a) ALT release and (b, c) histologi-
cal injury score. (d, e) Relative HO-1 expression in the control (C) and 
ischemic (I) lobes of Hmox-1+/− mice was approximately half that of 
wild-type animals.
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HO-1 expression is Kupffer cell dependent, and conversely 
that macrophage differentiation critically depends upon HO-1 
expression.
Numerous studies have employed gadolinium chloride and 
glycine to modulate Kupffer cell activity, and have shown these 
drugs to protect animals from hepatic ischemia.19,29–33 Such data 
give the impression that Kupffer cells have a harmful effect follow-
ing ischemia. We found that GdCl3 induced HO-1 and, as shown 
before in rats,31 reduced pro-inflammatory cytokine release. The 
effect of GdCl3 is thus somewhat complex and incompletely eluci-
dated: as such it provides limited information regarding the physi-
ological role of macrophage populations during ischemic insults.
To unpick the relative importance of circulating monocytes 
and Kupffer cells during ischemia–reperfusion insults, we selec-
tively ablated each population in CD11bDTR mice using  diphtheria 
toxin or LC, respectively. Kupffer cell but not circulating mono-
cyte ablation led to HO-1 deletion from the liver, and susceptibil-
ity to hepatic ischemic insults. Taken together with data showing 
the importance of TNF-α in causing IRI,7 and our own data 
showing HO-1 induction and reduction in TNF-α production 
from GdCl3-treated macrophages, these data suggest that the dif-
ferentiation state of tissue-resident macrophages is critical to the 
survival of surrounding parenchymal cells following ischemia. 
Tissue-resident macrophages could have their protective effect by 
modulation of immune responses to ischemically injured tissue,34 
by modulation of apoptosis induced directly by TNF-α35 or by 
release of carbon monoxide acting as a diffusible paracrine pro-
tective factor.36
As the immune system contributes so heavily to IRI, the site of 
hepatic HO-1 expression is the Kupffer cell, and previously  published 
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Figure 4 the effect of Hmox-1 copy number on Kupffer cell phenotype. Staining for F4/80, CD11b, CD68, CD206 (mannose receptor), MARCO, 
and Ly6c demonstrated that Hmox-1−/− Kupffer cell F4/80 expression is decreased, and MARCO and Ly6c expression is increased.
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data has shown such profound effects of HO-1 upon macrophage 
cytokine profiles,15,37 we hypothesized that differences in APC differ-
entiation might account for the susceptible phenotype of Hmox-1−/− 
mice. Indeed, Hmox-1−/− but not Hmox-1+/+ or +/− Kupffer 
cells expressed Ly6c which is found on inflammatory monocytes4 
and MARCO, which is associated with macrophage activation.21,22 
Hmox-1−/− Kupffer cells also expressed less F4/80, which has been 
implicated in modulation of adaptive immunity.25 Finally, HO-1 
induction decreased, and HO-1 inhibition increased, TNF-α secre-
tion following LPS stimulus. These in vivo findings were confirmed 
in vitro, with huge expansion of inflammatory monocyte subsets in 
the absence of HO-1. In contrast with other investigators,38 we did 
not find Hmox-1+/− animals to be susceptible to ischemic injury, 
a difference we attribute to subtle differences between IRI models 
developed in different laboratories. Although hmox-1+/− animals 
expressed less HO-1 protein than wild types, their lack of suscepti-
bility to ischemic injury correlates with their Kupffer cell phenotype 
which we found to be very similar to wild-type animals.
This work clarifies the role of macrophages in responses to 
ischemia–reperfusion insults and the effect of HO-1 upon mac-
rophage differentiation. The finding that HO-1 drives macrophage 
differentiation down an “anti-inflammatory” pathway provides 
potential insights into the mechanism of ischemic precondition-
ing which results in HO-1 induction and subsequent protection 
from injury. On the basis of data presented herein, it could be 
hypothesized that HO-1 induction during preconditioning might 
lead to alterations in the behavior of tissue-resident macrophages 
in response to ischemic insults and thus confer protection.
The ability of HO-1 to manipulate macrophage phenotype 
could be harnessed for therapeutic gain by infusion of exogenous 
“anti-inflammatory” macrophage populations, or by using agents 
such as heme arginate39 or curcumin40 to induce HO-1 in the 
patient to protect from ischemic injury.
The ability of HO-1 to dictate macrophage phenotype adds a 
further dimension to its apparently great therapeutic potential, 
offering new avenues for treatment of a range of common and 
deadly diseases with their pathophysiology rooted in IRI.
MaterIals and MetHods
Hmox-1−/−and Hmox-1+/− animals. All procedures and animal care 
were approved by institutional ethics committees and were in accordance 
with UK Home Office licensing regulations. C57/Bl6J animals with tar-
geted deletion of the Hmox-1 by neomycin resistance gene insertion26 were 
supplied by A Agarwal (Birmingham, Alabama), rederived and bred by 
heterozygote to heterozygote mating in accordance with local regulations.
Operative procedure. Operated animals underwent clamping of the portal 
pedicle (hepatic artery and portal vein) supplying the left hepatic under 
isoflurane anesthesia, with core temperature maintained at 36 °C through-
out. Preliminary experiments demonstrated optimal ischemic times of 
40 minutes for the detection of susceptible phenotypes, and 50 minutes 
for demonstration of protection from ischemic injury.41 Twenty fours 
hours after operation, animals were culled when blood and tissues were 
collected.
Experimental groups. Preliminary experiments demonstrated that 
the sham effect of surgery was negligible. Wild-type, Hmox-1+/−, and 
Hmox-1−/− mice underwent 40 minutes of ischemia (n = 6 per group). 
Two groups of C57Bl6J animals underwent 50 minutes of ischemia fol-
lowing injection of 20 mg/kg GdCl3 (Sigma-Aldrich, Poole, UK) or vehicle 
(n = 6 per group). Three groups (four per group) of CD11bDTR (SVB back-
ground) mice received 100 μl PBS (control), 25 ng/g DT, or 100 μl LC17 
(courtesy of Nico van Rooijen, www.clodronateliposomes.org) 24 hours 
before 40′ left hepatic lobar IRI.
ALT measurement. At 24 hours after ischemic insult, blood was taken 
via terminal cardiac puncture. ALT was measured on Olympus AU2700 
(Olympus Optical, Watford, UK) utilizing methodology recommended by 
the International Federation of Clinical Chemistry.
Histological injury scoring. Each animal was scored for necrosis and cyto-
plasmic injury on standardized scales by an experienced liver pathologist 
(C.O.B.) who was blinded to the experimental group and conditions. The 
two scores were added to give a single index of liver injury (maximum 
score 8). Degree of severity for the two parameters was determined as 
follows: for necrosis, 1 = increased single cell death (apoptosis, necrosis) 
without confluent necrosis; 2 = microfoci of confluent necrosis in a minor-
ity of lobules, not encircling the full circumference of the central vein; 3 = 
confluent necrosis in a majority of lobules, or confluent necrosis around 
the full thickness of the central vein >4 hepatocyte layers deep; 4 = pan-
lobular necrosis. For cytoplasmic injury, 1 = sparse and minor non-specific 
changes (minor microvesicular change), 2 = confluent perivenular hepato-
cyte cytoplasmic injury in a small minority of lobules (<25%), 3 = periv-
enular hepatocyte injury in 25–50% lobules, 4 = diffuse severe cytoplasmic 
injury in a majority (>50%) of lobules.
Western blot. Western blotting was performed as described  previously.12 
HO-1 was detected using rabbit polyclonal anti HO-1 (Stressgen SPA-
896; Nventa, San Diego, CA) diluted 1:5,000 in 1%BSA TBS 0.05% 
Tween. Loading control was Abcam mouse anti β-Actin (ab6276, Abcam, 
Cambridge, UK) diluted 1:10,000 in 1% BSA TBS 0.05% Tween. All anti-
bodies were used overnight at 4 °C.
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Figure 5 Monocyte and neutrophil counts in Hmox-1+/+ and 
Hmox-1−/− animals. (a) Monocyte counts in resting Hmox-1−/− ani-
mals were increased by 2.1-fold. This arose from a 2.5-fold expansion in 
immature Gr1hi monocytes and there was also a trend toward increased 
numbers of (b) Gr1lo monocytes, (c) although this did not achieve sta-
tistical significance. There was a trend toward increased numbers of neu-
trophils which again did not achieve statistical significance.
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Immunohistochemistry. Paraffin-fixed tissue sections underwent antigen 
retrieval by boiling in citrate buffer before goat serum, peroxide, avidin/
biotin blocking (Vector SP2001, Vector UK, Peterborough, UK) staining 
for HO-1 (Stressgen SPA 896). Secondary antibody was Dako goat anti-
rabbit biotinylated (E0432, Dako UK, Cambridgeshire). Finally, tertiary 
reagent (Vectastain elite pk-6100) was used before DAB color reagent 
and hematoxylin counterstain. For F4/80, antigen retrieval was with 
Proteinase-K (Dako S3020), primary antibody was rat anti-mouse F4/80 
(Serotec MCA497GA, Serotec, Oxford, UK), and secondary antibody 
was rabbit anti-rat biotinylated (Dako E0468). Immunohistochemistry 
for CD11b, CD68, Ly6c, CD206, and MARCO was performed on frozen 
sections. Primary antibodies were CD11b (Serotec MCA711G), CD68 
(Serotec MCA1957GA), Ly6c (Serotec MCA2389GA), CD206 (Serotec 
MCA2235GA), MARCO (Serotec MCA1849). Blocking, secondary, and 
tertiary steps were as for F4/80.
Preparation of bone marrow–derived monocytes. Femurs and tibias from 
8–10-week-old Hmox-1+/+, +/−, and −/− mice were harvested and grown 
as described elsewhere.18 At the point of marrow aspiration, cells from the 
femurs of the same animal were placed into paired cultures with the highly 
specific HO-1 inhibitor chromium mesoporphyrin IX (CrMP, Frontier 
Scientific, Logan, Utah) or vehicle (PBS).
Flow cytometry. BMDMs were stained with biotinylated anti-mouse Gr1 
(eBioscience RB6-8D5, eBioscience, San Diego, CA), PE-conjugated anti 
F4/80 (eBioscience clone BM8), PerCP-Cy5.5-labeled anti-CD11b (eBio-
science M1/70) and FITC-conjugated anti-CD68 FITC (Acris SM1550F, 
Acris Antibodies GmbH, Germany), following permeabilization with 
Cytoperm plus (BD 554715; Becton Dickinson, Franklin Lakes, NJ), or 
with biotinylated anti-mouse Ly6c (cat. no. 557359, clone AL21; Becton 
Dickinson, Oxford, UK; Pharmingen, Oxford, UK), FITC-conjugated anti-
F4/80 (Serotec, Oxford, UK, cat no. MCA497F, clone A3-1), PE-conjugated 
CD11c (clone N418, cat no. 12-0114-83, eBioscience), PerCP-Cy5.5-labeled 
anti-CD11b (BD Pharmingen cat. no. 550993, clone M1/70). Experiments 
were conducted on cells from paired, age-, and sex-matched wild type, 
Hmox-1+/− and −/− animals at 7 days of maturation, four animals per 
group. Samples were analyzed on a BD FACScalibur flow cytometer and 
analyzed using Flow-Jo software (Tree Star, Ashland, OR).
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Figure 6 the effect of Ho-1 function upon macrophage differentiation in vitro. Suspension cultures of Hmox-1+/+, +/−, and −/− bone marrow–
derived stem cells were grown in M-CSF conditioned medium for 6 days. Wild-type cells were grown in the presence or absence of the highly specific 
HO-1 inhibitor CrMP throughout their maturation. Hmox-1−/− and wild-type HO-1 inhibited BMDMs were considerably (a) more numerous than 
control wild-type BMDMs. Flow cytometry demonstrated development of a large F4/80− population in (b, c) HO-1 inhibited cultures. (d) Dot plots 
indicated that Ly6c and CD11c markers were seen on mutually exclusive populations. Calculation of cell numbers demonstrated that HO-1 inhibition 
led to expansion of a large pro-inflammatory (e) Ly6c+, (f) CD11c− population. LPS stimulus of BMDMs in vitro led to increased TNF-α production in 
conditions of (g) HO-1 inhibition and (h) decreased TNF-α secretion when HO-1 was induced.
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Macrophage TNF-α production studies. Day 7 BMDMs were plated at a 
density of 1 × 105 cells per well in 24 well plates, 1 day before stimulus. 
Before the addition of LPS 500 ng/ml, cells were preincubated with medium 
containing CrMP (5 µmol/l) or plain medium for 1 hour. Supernatants 
were collected after 2 hours and immediately frozen at −20 °C until ELISA 
analysis. ELISA for mouse TNF-α was performed using a “Duoset” kit 
obtained from R&D systems (Minneapolis, MN) according to the manu-
facturer’s instructions. Experiments were repeated three to five times with 
cells derived from separate animals.
Statistical analysis. Datasets were prepared using Microsoft Excel. 
Statistical analysis was performed using Minitab 13 for Windows XP. 
Comparison of means was performed using unpaired two-tailed, paramet-
ric t tests (in vivo data, in vitro “between plate” data) or paired two-tailed, 
parametric t tests (in vitro, same plate data). P values of ≤0.05 were taken 
as significant. Data are presented as mean ± SEM.
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